The price of sight - Ranibizumab, bevacizumab, and the treatment of macular degeneration

被引：169
|
作者：
Steinbrook, Robert
机构：
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 355卷 / 14期
关键词：
D O I：
10.1056/NEJMp068185
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1409 / 1412
页数：4
相关论文
共 50 条
  • [1] Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
    Martin, Daniel F.
    Maguire, Maureen G.
    Fine, Stuart L.
    Ying, Gui-shuang
    Jaffe, Glenn J.
    Grunwald, Juan E.
    Toth, Cynthia
    Redford, Maryann
    Ferris, Frederick L., III
    [J]. OPHTHALMOLOGY, 2012, 119 (07) : 1388 - 1398
  • [2] EFFICACY AND SAFETY OF RANIBIZUMAB AND BEVACIZUMAB IN TREATMENT FOR AGE RELATED MACULAR DEGENERATION
    Saturnino, L. T. M.
    Silveira, M. R.
    Guerra Junior, A. A.
    Acurcio, F. D. A.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A667 - A668
  • [3] Bevacizumab versus ranibizumab for the treatment of neovascular age- related macular degeneration
    Soiberman, Uri
    Loewenstein, Anat
    [J]. EXPERT REVIEW OF OPHTHALMOLOGY, 2010, 5 (05) : 603 - 615
  • [4] Pharmacogenetics of the Treatment Response of Age-Related Macular Degeneration with Ranibizumab and Bevacizumab
    Kanoff, Justin
    Miller, Joan
    [J]. SEMINARS IN OPHTHALMOLOGY, 2013, 28 (5-6) : 355 - 360
  • [5] Ranibizumab versus bevacizumab for the treatment of neovascular age-related macular degeneration
    Abouammoh, Marwan
    Sharma, Sanjay
    [J]. CURRENT OPINION IN OPHTHALMOLOGY, 2011, 22 (03) : 152 - 158
  • [6] Bevacizumab versus ranibizumab in the treatment of exudative age-related macular degeneration
    Gamulescu M.-A.
    Radeck V.
    Lustinger B.
    Bianca Fink B.
    Helbig H.
    [J]. International Ophthalmology, 2010, 30 (3) : 261 - 266
  • [7] AGE RELATED MACULAR DEGENERATION Cost comparison of ranibizumab and bevacizumab
    Jackson, Timothy L.
    Kirkpatrick, Lucy
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
  • [8] Saving money on the PBS: ranibizumab or bevacizumab for neovascular macular degeneration?
    Harvey, Ken J.
    Day, Richard
    Campbell, William G.
    Lipworth, Wendy
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2011, 194 (11) : 567 - 568
  • [9] RANIBIZUMAB AND BEVACIZUMAB FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION: A SYSTEMATIC REVIEW AND ECONOMIC EVALUATION
    Martinez Ferez, I. M.
    Flores Moreno, S.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A503 - A504
  • [10] COMPARISON OF INTRAVITREAL BEVACIZUMAB FOLLOWED BY RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Stepien, Kimberly E.
    Rosenfeld, Philip J.
    Puliafito, Carmen A.
    Feuer, William
    Shi, Wei
    Al-Attar, Luma
    Dubovy, Sander R.
    Murray, Timothy G.
    Davis, Janet L.
    Lee, Wen-Hsiang
    Schwartz, Stephen G.
    Smiddy, William E.
    Berrocal, Audina M.
    Flynn, Harry W., Jr.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (08): : 1067 - 1073
12345